PAROLINI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 6.130
AS - Asia 3.245
EU - Europa 2.857
SA - Sud America 436
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 66
OC - Oceania 18
Totale 12.952
Nazione #
US - Stati Uniti d'America 6.026
CN - Cina 1.433
SG - Singapore 882
PL - Polonia 761
UA - Ucraina 534
IT - Italia 385
BR - Brasile 368
DE - Germania 282
HK - Hong Kong 263
FR - Francia 210
FI - Finlandia 201
IN - India 168
VN - Vietnam 167
GB - Regno Unito 163
TR - Turchia 93
IE - Irlanda 89
RU - Federazione Russa 81
BD - Bangladesh 66
CA - Canada 61
SE - Svezia 38
AR - Argentina 27
KR - Corea 26
BE - Belgio 23
IQ - Iraq 22
MX - Messico 20
NL - Olanda 20
ZA - Sudafrica 19
AU - Australia 18
JP - Giappone 18
ID - Indonesia 17
ES - Italia 15
MA - Marocco 13
CO - Colombia 12
SA - Arabia Saudita 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
AT - Austria 10
NG - Nigeria 10
PK - Pakistan 10
UZ - Uzbekistan 9
KZ - Kazakistan 8
LT - Lituania 8
MU - Mauritius 7
AZ - Azerbaigian 6
EU - Europa 6
JM - Giamaica 6
LB - Libano 6
PH - Filippine 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
KE - Kenya 5
VE - Venezuela 5
GR - Grecia 4
IR - Iran 4
JO - Giordania 4
RO - Romania 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
AM - Armenia 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TJ - Tagikistan 1
Totale 12.758
Città #
Warsaw 760
Fairfield 640
Ashburn 530
Singapore 488
Woodbridge 452
Shenzhen 406
Jacksonville 371
Houston 357
Chandler 296
Cambridge 278
Ann Arbor 269
Hong Kong 258
Seattle 247
San Jose 231
Wilmington 229
Beijing 204
Brescia 155
Princeton 153
Nanjing 152
New York 146
The Dalles 133
Los Angeles 126
Helsinki 107
Council Bluffs 106
Dearborn 87
Dublin 87
Lauterbourg 78
Dallas 68
Columbus 65
Istanbul 63
Nanchang 57
Buffalo 56
Ho Chi Minh City 50
Munich 48
Milan 41
Changsha 39
Jinan 39
Moscow 36
San Diego 36
São Paulo 35
Des Moines 34
Santa Clara 34
Shenyang 34
Chicago 32
London 31
San Francisco 31
Tianjin 30
Hanoi 29
Hebei 27
Phoenix 26
Redondo Beach 25
Shanghai 25
Turku 25
Brussels 20
Dong Ket 20
Montreal 20
Orem 20
Seongnam 19
Toronto 18
Tokyo 17
Brooklyn 16
Verona 16
Zhengzhou 16
Jiaxing 15
Kocaeli 15
Charlotte 14
Hangzhou 14
Rio de Janeiro 14
Stockholm 14
Genova 13
Indianapolis 13
Kunming 13
Chennai 12
Jakarta 12
Johannesburg 12
Ningbo 12
Rome 12
Atlanta 11
Augusta 11
Denver 11
Mexico City 11
Taizhou 11
Abuja 10
Changchun 10
Frankfurt am Main 10
Manchester 10
Washington 10
Amsterdam 9
Boardman 9
Brasília 9
Haikou 9
Lanzhou 9
Leawood 9
Tashkent 9
Brno 8
Haiphong 8
Mumbai 8
Poplar 8
Lancaster 7
Lappeenranta 7
Totale 8.943
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 582
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 398
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 390
NFKB1 regulates human NK cell maturation and effector functions 347
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 303
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. 301
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 236
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 225
CTLA-4 regulates human Natural Killer cell effector functions 212
The RAC2-PI3K axis regulates human NK cell maturation and function 211
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 206
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 201
Activin A as a Mediator of NK-Dendritic Cell Functional Interactions. 201
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 197
Functional Characterization Of Natural Killer Cells In Type I Leukocyte Adhesion Deficiency 194
Effects of opioid therapy on human natural killer cells. 192
Biological characterization and in vitro effects of human concentrated growth factor preparation: An innovative approach to tissue regeneration 191
Inherited DOCK2 deficiency in patients with early-onset invasive infections 189
2B4 functions as a co-receptor in human NK cell activation 172
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 169
Selective cross-talk among natural cytotoxicity receptors in human natural killer cells 159
Cellular and molecular pathogenesis of X-linked lymphoproliferative disease. 159
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 159
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 158
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 156
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 151
NK cells at the interface between innate and adaptive immunity 150
X-linked lymphoproliferative disease: the dark side of 2B4 function. 145
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 144
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 144
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 144
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients 143
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 141
La sindrome emofagocitica: dai sintomi alle cause genetiche 140
Novel insights from adaptor protein 3 complex deficiency 140
CD59 is physically and functionally associated to Natural Citotoxicity Receptors and activates human NK cell mediated cytotoxicity. 139
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 139
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 138
Human natural killer cell receptors and co-receptors 136
Basement Membrane Components in Normal, Dysplastic and Neoplastic Epithelia of the Uterine Cervix 136
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 136
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 134
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 133
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 133
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 133
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient 133
Identification of NKp80, a novel triggering molecule expressed by human NK cells 132
Pseudorabies virus US3 protein kinase protects infected cells from NK cell-mediated lysis via increased binding of the inhibitory NK cell receptor CD300a 132
Development of chicken embryos exposed to an intermittent horizontal sinusoidal 50 Hz magnetic field. 129
[Distribution of laminin, type IV collagen and fibronectin in normal, dysplastic and neoplastic laryngeal tissue]. 129
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 124
CD94 functions as a natural killer cells inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 124
NK cells and their receptors during viral infections. 124
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 123
IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cell and acquisition of surface killer Ig-like receptors 121
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 118
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 118
Identification and Molecular Characterization of NKp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells. 115
P85α is an intrinsic regulator of human natural killer cell effector functions 115
The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles 112
Function and specificity of human natural killer cell receptors. 111
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells 111
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 110
Triggering Receptors involved in Natural Killer cell mediated cytotoxicity against Choriocarcinomas cells lines 106
The LIR-1 receptor for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles. 106
IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interaction with Cells or Tumors 105
Natural killer cell impairment in ovarian clear cell carcinoma 104
In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines 103
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications 102
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes Natural Killer Cell Activation 102
Linker for Activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes. Evaluation in normal and pathological conditions 101
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 100
Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes 100
FGF-trapping hampers cancer stem-like cells in uveal melanoma 99
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 98
Immunohistochemical localization of laminin, collagen IV and fibronectin in dysplasias and neoplasms of the cervix uteri 96
Immunocytochemical localization of plasminogen activators in carcinomas in the cervix and vulva. 94
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 93
Impaired natural and CD16-mediated NK cell cytotoxic function in WAS and XLT patients: ability of IL-2 to correct NK cell functional defect 92
Distribuzione di laminina, collagene di tipo IV e fibronectina nel tessuto laringeo normale, displastico e neoplastico. 88
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 85
LAT (Linker for activation of T cells): A novel immunohistochemical marker for T, NK, mast cells and megakaryocytes. Evaluation in normal and pathological conditions. 81
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of Natutal Killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease 78
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 39
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 34
Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas 33
Heparin-binding Proteins Drive The Resistance To Anti-VEGF Therapies In Diabetic Retinopathy 9
Role of heparin-binding mediators in the resistance to anti-VEGF therapies in diabetic retinopathy 8
FGF-trapping hampers cancer stem-like cells in uveal melanoma 8
Totale 12.952
Categoria #
all - tutte 57.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022577 0 0 15 52 16 26 30 42 48 106 53 189
2022/2023787 120 7 14 93 55 216 7 88 105 7 37 38
2023/20241.022 43 10 469 30 28 131 38 44 128 4 9 88
2024/20251.368 13 4 9 187 164 113 112 68 165 75 285 173
2025/20262.985 280 366 277 410 302 198 427 137 204 221 86 77
2026/2027412 140 157 115 0 0 0 0 0 0 0 0 0
Totale 12.952